Acute Respiratory Distress Syndrome News and Research

RSS

COVID-19 pandemic: An epidemiological update

Epidemics and pandemics have been frightening the human chase again and again. SARS, H1N1, Ebola, and more have exposed their real face in the past, but with every such outbreak.

25 Aug 2022

The incidence rates of adverse events of special interest in COVID-19 vaccinated and non-vaccinated persons

Researchers monitored the safety of the four diverse SARS-CoV-2 vaccines approved by the EMA and MHRA in 2020 to 2021.

24 Aug 2022

Transposable element expression changes in response to SARS-CoV-2 infection

Researchers observed that transposable element activation is impaired during infection with SARS-CoV-2.

24 Aug 2022

Non-hospitalized COVID patients show only minor cognitive impairments at long-term follow up

Now, a new study published in the PLOS ONE journal aims to analyze cognitive deficits in non-hospitalized patients 8 to 13 months post-COVID-19.

23 Aug 2022

A combined influenza and COVID-19 mRNA vaccine

A combined mRNA vaccine is capable of inducing broad and durable protection against co-infection with SARS-CoV-2 and IAV,

3 Aug 2022

Nasal epithelium of children inhibits infection and replication of ancestral SARS-CoV-2

SARS-CoV-2 causes a broad range of clinical symptoms, including potentially fatal acute respiratory distress syndrome (ARDS).

1 Aug 2022

How and when do de novo SARS-CoV-2 spike mutations emerge?

Researchers evaluated viral mutations in two patients with persistent SARS-CoV-2 infection.

1 Aug 2022

Decoy ACE2 receptors broadly neutralize SARS-CoV-2 variants

Researchers review current developments in preclinical studies associated with recombinant ACE2 decoy receptors against coronaviruses.

31 Jul 2022

Is cannabidiol effective against COVID-19?

A new study discusses the utility of CBD in treating the inflammatory symptoms of COVID-19

31 Jul 2022

The effects of CBD in the treatment of COVID-19–related inflammatory symptoms

Researchers reviewed the effectiveness of cannabidiol in treating COVID-19 inflammatory-related symptoms.

28 Jul 2022

Phase 2a clinical trial describes safety and efficacy of dendrimer nanotherapy in severe COVID-19 patients

A multicenter, randomized, placebo-controlled phase 2a clinical trial has recently been conducted to evaluate the efficacy of a nanotherapeutic compound OP-101 in treating severe COVID-19 patients.

21 Jul 2022

Smoking increases risk of severe COVID-19 outcomes in hospitalized patients

New research assessed the association of smoking with COVID-19 complications.

20 Jul 2022

Decline in mental health during pregnancy throughout the COVID-19 lockdown period

A new study examined the changes in the mental state of pregnant women over the first COVID-19-related lockdown in France, and the persistence of anxiety-related symptoms over the two months following the end of the lockdown.

18 Jul 2022

The pathobiology, host response, and effects of SARS-CoV-2 on the respiratory and intestinal microbiome

Researchers investigated the effect of influenza A virus pre-exposure and SARS-CoV-2 infection in the elderly population using a 14-month-aged golden Syrian hamsters model.

18 Jul 2022

Novel nanoligomer approach to treat severe COVID-19

Researchers discuss the biodistribution and safety of a novel nanoligomer SBCoV207, which was used to targeted miR-2392 in a murine model.

17 Jul 2022

Minimally invasive skin biopsy can help assess tissue damage related to SARS-CoV-2 infection

Using skin biopsy samples, investigators found that patients with severe COVID-19 had clots in small venous and arterial blood vessels in skin that appears normal.

14 Jul 2022

Lipids in breastmilk may protect against metabolic disease later in life

A new study examines the lipid content in breastmilk and its association with NCDs later in life.

13 Jul 2022

Experimental model reveals possible causes and treatments for long-COVID

In a recent study published in the journal Science Translational Medicine, researchers characterized long-term pulmonary consequences of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) mouse-adapted strain (MA10) infection in BALB/c laboratory mice.

11 Jul 2022

Targeting C5a/C5aR1 signaling ameliorates COVID-19 immunopathology

A new study investigated the role of complement component 5a (C5a) and its receptor (C5a receptor type 1, C5aR1) in the pathophysiology of COVID-19.

6 Jul 2022

SARS-CoV-2 infection of lung endothelial cells and pulmonary capillary microthrombosis

Researchers evaluated the presence of RNA of SARS-CoV-2 in lung tissue of deceased patients.

4 Jul 2022